Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06833502 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

StatusRecruiting
PhasePhase 2
Started2025-02-24
View on ClinicalTrials.gov ↗

Amendment history

2026-06-30
Study Status, Contacts/Locations v6
Re-verified, no change to tracked fields
2026-03-31
Study Status v5
Primary completion pushed: 2026-08 → 2026-10
Completion pushed: 2026-08 → 2026-10
2026-01-29
3 amendments v2-v4
3 re-verifications since 2025-06-18, no change to tracked fields
2025-03-13
Study Status v1
Start dateestimated 2025-03-01→confirmed 2025-02-24
2025-02-13
Original filing
The purpose of the study is to determine the frequency of systemic metastasis in node positive breast cancer following chemotherapy and surgery. Participants will be asked to spend about 6 months in this study. Participants will undergo a computed tomography (CT) screening of the thorax, abdomen, and pelvis at baseline prior to adjuvant radiation therapy and another CT screening of the thorax, abdomen, and pelvis at 6 months if the baseline CT is found to be negative.
Trial Details
NCT Number NCT06833502
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Florida Breast Cancer Foundation
Conditions Breast Cancer, Node-positive Breast Cancer
Enrollment 120 participants
Start Date 2025-02-24
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-02